Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
NCT00117143
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombocytopenic Purpura
Interventions
DRUG:
Romiplostim
Sponsor
Amgen